Cleanspark price to sales ratio CLSK
Market value divided by revenue over the last twelve months, since 2019.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- 6.5×
- May 2025
- 7-year median
- 7.6×
- 7-year range
- 0.7× to 93.0×
- Peer median
- 1.6×
Cleanspark's price to sales ratio is not a meaningful number today: revenue for one or more of the four quarters through 2026-06-30 is missing, so twelve months can't be added up.
It was last meaningful in May 2025, at 6.5×.
On the days it had one over the last 7 years, its median was 7.6×, from 0.7× in Dec 2022 to 93.0× in Jan 2021.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2025 | 6.5× | 5.3× | 9.2× |
| 2024 | 7.6× | 5.9× | 19.6× |
| 2023 | 12.1× | 1.1× | 13.0× |
| 2022 | 1.0× | 0.7× | 6.9× |
| 2021 | 8.0× | 8.0× | 93.0× |
| 2020 | 69.4× | 1.3× | 69.4× |
| 2019 | 17.0× | 17.0× | 18.0× |
Against its peers
Companies in Financial - Credit Services nearest Cleanspark's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| CLSKCleanspark | n/m |
| WUWestern Union CO | 0.5× |
| ECPGEncore Capital | 1.1× |
| AGMFederal Agricultural Mortgage | 4.9× |
| UPSTUpstart | 1.9× |
| FLYWFlywire | 3.3× |
| PAYOPayoneer Global | 2.2× |
| EEFTEuronet Worldwide | 0.6× |
| HAPNHappen | 1.6× |
| PGYPagaya Technologies | 1.1× |
| NUTXNutex Health | 1.7× |
| Peer median | 1.6× |
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Cleanspark
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.